Clinical Trial Update: A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial completed to evaluate the pharmacokinetic interactions between BMS-986177 and co-administered itraconazole or diltiazem in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• BMS-986177
• Diltiazem (diltiazem)
• Itraconazole (Itraconazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED